At what enterprise value was DENTALCORP acquired in 2026?

During the acquisition of DENTALCORP by GTCR in 2026, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 3b - 100b CAD. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 14.8x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of DENTALCORP when it was acquired by GTCR?

The estimated EV/EBITDA multiple for DENTALCORP is in the range of 10x - 18x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 14.8x. Join our community for free to access full valuation data and industry trends.

When was DENTALCORP acquired by GTCR?

DENTALCORP was acquired by GTCR in 2026.

What was the revenue of DENTALCORP at the time of the deal?

The revenue of DENTALCORP at the time of the deal is estimated to be in the range of 1b - 3b CAD. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of DENTALCORP during the acquisition?

DENTALCORP's EBITDA is estimated to be in the range of 250M - 500M CAD. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the DENTALCORP acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the DENTALCORP deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.gtcr.com/dentalcorp-agrees-to-be-acquired-by-investment-funds-affiliated-with-gtcr-in-c2-2-billion-transaction/

← DATABASE

Home Database Healthcare & PharmaDENTALCORP

01/2026

DENTALCORP acquired by GTCR

CANADA Health Providers / Outpatient Care / Dental Centers EV 3b - 100b CAD

Context

Dentalcorp Holdings Ltd. has successfully completed a statutory plan of arrangement to be acquired by an acquisition vehicle affiliated with GTCR. Under the terms of the agreement, GTCR acquired all issued and outstanding subordinate and multiple voting shares for C$11.00 per share in cash. The transaction represents a premium of approximately 33% over the 20,day volume weighted average trading price prior to the initial announcement in September 2025. Following the completion of the deal, the company is expected to be de,listed from the Toronto Stock Exchange and will cease to be a reporting issuer in Canada. As part of the strategic structure, the founder and senior executive leadership, alongside certain partner dentists, rolled a significant portion of their existing shares into the post,closing capital structure. This rollover ensures leadership continuity and aligns the interests of the management team with the new private ownership. The acquisition provides the organization with enhanced flexibility as a private entity to invest in technology, patient care infrastructure, and professional development. The transaction was unanimously recommended by a Special Committee of independent directors and the Board of Directors, following a comprehensive negotiation process designed to crystallize value for shareholders while supporting the group's long,term expansion.

DENTALCORP, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Dentalcorp Holdings operates as the largest network of dental practices in Canada, establishing itself as a premier dental support organization in North America. The organization focuses on acquiring leading dental practices and uniting them under a common tech,enabled platform. This model allows dental professionals to retain their clinical autonomy while leveraging the group's significant scale, industry,leading technology, and specialized know,how to drive future growth. The entity is committed to delivering high,quality clinical outcomes and predictable patient experiences across its extensive national footprint. By providing comprehensive administrative and strategic support, the group enables practitioners to focus on patient care and overall well,being. The business is characterized by a high recurring patient visit rate and a robust acquisition strategy that continuously expands its reach within the Canadian healthcare market.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (CAD)

Year

Rev

EBITDA

EBIT

2025

2024

Similar deals in Healthcare & Pharma

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
04/2026	COLOSSEUM DENTAL GROUP	MEDICALSAN	ITALY	Health Providers	Colosseum Dental Group has successfully finalized the acquisition of 100% of Medicalsan, marking a significant step in its strategic geographic densification within the Italian dental market. This transaction follows a series of successful integrations of regional hubs in Italy, reinforcing the group's objective to consolidate the fragmented national healthcare landscape
02/2026	MERIEUX EQUITY PARTNERS	HEALTH IN CODE (HIC)	SPAIN	Health Providers	Merieux Equity Partners acquired a significant minority stake in Health in Code, joining forces with Alantra and the management team. The transaction aims to provide the capital and industrial expertise needed to double the company's size, with a goal of reaching EUR100 million in revenue within five years
01/2026	POINT VISION	CLINIQUE DE LA VISION (REFRACT SAS)	FRANCE	Health Providers	Point Vision acquired a controlling stake in Refract SAS, the parent company of Clinique de la Vision. This acquisition allows Point Vision to integrate a leading refractive surgery capability into its vast consultation network
12/2025	TERVEYSTALO HEALTHCARE	HOHDE GROUP	FINLAND	Health Providers	Terveystalo signed an agreement to acquire Hohde Group, comprising Hammas Hohde Oy and Loisto Laboratoriot Oy, in a transaction financed through debt committed by Terveystalo's existing partner banks. The acquisition is subject to approval by the Finnish Competition and Consumer Authority
11/2025	CIR - COMPAGNIE INDUSTRIALI RIUNITE	KOS GROUP	ITALY	Health Providers	CIR has signed a binding agreement to acquire the remaining 40.23% stake in KOS Group from F2i Healthcare (controlled by F2i Sgr and its co-investors), moving to 100% ownership. The strategic rationale for the transaction is to consolidate full industrial control over CIR's most strategic asset, enabling simplified governance and a more agile execution of KOS's expansion plans in Italy and Germany
11/2025	METRIC CAPITAL PARTNERS	EXCELLENCE IMAGERIE	FRANCE	Health Providers	The Paris-based radiology group with approximately EUR80 million in revenue, backed since 2019 by UI Investissement, has just concluded a second LBO under the impetus of Metric Capital Partners, which would value it between EUR350 million and EUR400 million, according to our information, a little over a year after the abandonment of its takeover by Antin IP
10/2025	GROUPE RESONANCE IMAGERIE	CIMEP	FRANCE	Health Providers	Groupe Resonance Imagerie, a french medical imaging group supported by Andera Partners for the past three years, is pursuing its geographical consolidation strategy by acquiring the Parisian company Cimep, which brings it 12 centers and nearly EUR20 million in additional revenue
07/2025	BRIDGEPOINT	MYDENTIST	UNITED KINGDOM	Health Providers	Bridgepoint acquired MyDentist from its long-term owners (likely Palamon Capital Partners and The Carlyle Group). Bridgepoint aims to accelerate the group's pivot from low-margin NHS contracts toward high-growth private treatments (implants, aesthetics, clear aligners)
05/2025	FONDATION SANTE SERVICE	CLARIANE HAD (HOME HOSPITALIZATION SERVICES)	FRANCE	Health Providers	Clariane sells its French home hospitalization business to the leader of the sector in France, Fondation Sante Service. The deal is part of Clariane's EUR1bn asset disposal plan to strengthen its balance sheet
04/2025	EUROFINS SCIENTIFIC	SYNLAB SPAIN	SPAIN	Health Providers	Eurofins Scientific has completed the acquisition of 100% of SYNLAB’s clinical diagnostics operations in Spain. The transaction, initially agreed upon in October 2024, was finalized on March 31, 2025. This strategic carve-out allows SYNLAB to optimize its portfolio by exiting the Spanish market to focus on regions with higher strategic impact

REFERENCES

Valuation range: EV 3b - 100b CAD

Revenue range: 1b - 3b CAD

EBITDA range: 250M - 500M CAD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DENTALCORP by GTCR are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Target: dentalcorp

Acquirer: gtcr